Form 8-A12B Papa Medical Inc.

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-A

 

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

Papa Medical Inc.

(Exact name of Registrant as specified in Its charter)

 

 

Delaware		99-0986423
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

 

202 North California Ave

City of Industry, CA 91744

(Address of principal executive offices)

 

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class to be so registered		Name of each exchange on which each class is to be registered
Class A Common Stock, par value US$0.0001 per share		The Nasdaq Stock Market LLC

 

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A. (c) or (e), check the following box. ☒

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A. (d) or (e), check the following box. ☐

 

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐

 

Securities Act registration statement file number to which this form relates: 333-283405.

 

Securities to be registered pursuant to Section 12(g) of the Act: None

 

 

 

ITEM 1. DESCRIPTION OF REGISTRANT’S SECURITIES TO BE REGISTERED.

 

The description of the securities to be registered is contained in a prospectus that forms a part of the registrant’s Registration Statement on Form S-1 (File No. 333-283405) originally filed with the Securities and Exchange Commission on November 22, 2024, as amended, relating to such securities and is to be filed pursuant to Rule 424(b) under the Securities Act of 1933 (such prospectus as filed pursuant to Rule 424(b), the “Prospectus”). The description of the securities contained in the Prospectus is hereby incorporated by reference into this Form 8-A. Copies of such description will be filed with The Nasdaq Stock Market LLC.

 

ITEM 2. EXHIBITS.

 

No exhibits are required to be filed as the securities being registered on this form (1) are being registered on an exchange on which no other securities of the Registrant are registered, and (2) are not being registered pursuant to Section 12(g) of the Exchange Act.

 

 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

	Papa Medical Inc.
	By:	/s/ Jian Hua
	Name:	Jian Hua
	Title:	Chief Executive Officer and Director

 

July 18, 2025

 

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Invitation to media and analyst briefing for Ericsson Q3 2026 report
• Italy’s Finance Leaders Face a Multi-Day Risk Visibility Gap
• Three in Four Travelers Get Their ESTA, UK ETA or eTA Right the First Time, Service eVisa Index Finds